| Dr Scott W Mckinney, DPM | |
|
3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505-3137 | |
| (713) 946-1500 | |
| (713) 946-0200 |
| Full Name | Dr Scott W Mckinney |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 35 Years |
| Location | 3692 E Sam Houston Pkwy S, Pasadena, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003866179 | NPI | - | NPPES |
| 121564203 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | 1103 (Texas) | Secondary |
| 213E00000X | Podiatrist | 1103 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mckinney Podiatric Associates Pa | 3072540731 | 7 |
News Archive
KIKA Clinical Solutions, the leading provider of advanced EDC solutions for clinical trials, continues leading the industry in providing solutions that go well beyond traditional EDC with the release of Veracity™ 3.7.
Analysis from business intelligence provider GBI Research - Rheumatoid Arthritis Market to 2020 - says that the global Rheumatoid Arthritis (RA) treatment market is expected to increase in value, from $14.3 billion in 2013 to just over $19 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 4.1%.
Experiencing speed and efficiency in the healthcare process remains a rarity. Now two companies are adding those essential variables to ensure healthy, accurate outcomes. Rising Medical Solutions, a medical cost containment company, and Align Networks, a physical medicine provider network, have built an electronic integration that picks up the pace of healthcare.
Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
› Verified 2 days ago
| Provider Name | Mckinney Podiatric Associates Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538194394 PECOS PAC ID: 3072540731 Enrollment ID: O20050725000524 |
News Archive
KIKA Clinical Solutions, the leading provider of advanced EDC solutions for clinical trials, continues leading the industry in providing solutions that go well beyond traditional EDC with the release of Veracity™ 3.7.
Analysis from business intelligence provider GBI Research - Rheumatoid Arthritis Market to 2020 - says that the global Rheumatoid Arthritis (RA) treatment market is expected to increase in value, from $14.3 billion in 2013 to just over $19 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 4.1%.
Experiencing speed and efficiency in the healthcare process remains a rarity. Now two companies are adding those essential variables to ensure healthy, accurate outcomes. Rising Medical Solutions, a medical cost containment company, and Align Networks, a physical medicine provider network, have built an electronic integration that picks up the pace of healthcare.
Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott W Mckinney, DPM 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505-3137 Ph: (713) 946-1500 | Dr Scott W Mckinney, DPM 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505-3137 Ph: (713) 946-1500 |
News Archive
KIKA Clinical Solutions, the leading provider of advanced EDC solutions for clinical trials, continues leading the industry in providing solutions that go well beyond traditional EDC with the release of Veracity™ 3.7.
Analysis from business intelligence provider GBI Research - Rheumatoid Arthritis Market to 2020 - says that the global Rheumatoid Arthritis (RA) treatment market is expected to increase in value, from $14.3 billion in 2013 to just over $19 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 4.1%.
Experiencing speed and efficiency in the healthcare process remains a rarity. Now two companies are adding those essential variables to ensure healthy, accurate outcomes. Rising Medical Solutions, a medical cost containment company, and Align Networks, a physical medicine provider network, have built an electronic integration that picks up the pace of healthcare.
Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
› Verified 2 days ago
Francisco J Cuza, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Dr. Edward M. Jacquet Iii, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 5119 Fairmont Parkway, Suite B-2, Pasadena, TX 77505 Phone: 713-910-5577 Fax: 713-910-1992 | |
Texas Mobile Foot Consultants, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3222 Burke Rd, Suite 102, Pasadena, TX 77504 Phone: 713-948-0400 Fax: 713-948-0401 | |
Dr. Jorge L Cuza, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3692 E Sam Houston Pkwy S, Suite 100, Pasadena, TX 77505 Phone: 713-946-1500 Fax: 713-946-0200 | |
Fein Foot And Ankle Center Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6243 Fairmont Pkwy Ste 203c, Pasadena, TX 77505 Phone: 832-301-9871 Fax: 281-630-2954 | |
Bruce Miller, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6021 Fairmont Pkwy, Ste 130, Pasadena, TX 77505 Phone: 281-991-0600 Fax: 281-991-0638 |